Cite

HARVARD Citation

    Morse, M. et al. (n.d.). Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: comparison of immune responses in stage III and stage IV patients. Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record